459 related articles for article (PubMed ID: 32976566)
1. Role and therapeutic potential of liquid-liquid phase separation in amyotrophic lateral sclerosis.
Pakravan D; Orlando G; Bercier V; Van Den Bosch L
J Mol Cell Biol; 2021 Apr; 13(1):15-28. PubMed ID: 32976566
[TBL] [Abstract][Full Text] [Related]
2. TAR DNA-binding protein 43 (TDP-43) liquid-liquid phase separation is mediated by just a few aromatic residues.
Li HR; Chiang WC; Chou PC; Wang WJ; Huang JR
J Biol Chem; 2018 Apr; 293(16):6090-6098. PubMed ID: 29511089
[TBL] [Abstract][Full Text] [Related]
3. Metals in ALS TDP-43 Pathology.
Koski L; Ronnevi C; Berntsson E; Wärmländer SKTS; Roos PM
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830074
[TBL] [Abstract][Full Text] [Related]
4. Human TDP-43 and FUS selectively affect motor neuron maturation and survival in a murine cell model of ALS by non-cell-autonomous mechanisms.
Wächter N; Storch A; Hermann A
Amyotroph Lateral Scler Frontotemporal Degener; 2015; 16(7-8):431-41. PubMed ID: 26174443
[TBL] [Abstract][Full Text] [Related]
5. "STRESSED OUT": The role of FUS and TDP-43 in amyotrophic lateral sclerosis.
Aksoy YA; Deng W; Stoddart J; Chung R; Guillemin G; Cole NJ; Neely GG; Hesselson D
Int J Biochem Cell Biol; 2020 Sep; 126():105821. PubMed ID: 32758633
[TBL] [Abstract][Full Text] [Related]
6. An aberrant fused in sarcoma liquid droplet of amyotrophic lateral sclerosis pathological variant, R495X, accelerates liquid-solid phase transition.
Shiramasa Y; Yamamoto R; Kashiwagi N; Sasaki F; Imai S; Ike M; Kitazawa S; Kameda T; Kitahara R
Sci Rep; 2024 Apr; 14(1):8914. PubMed ID: 38632300
[TBL] [Abstract][Full Text] [Related]
7. Aggregation of FET Proteins as a Pathological Change in Amyotrophic Lateral Sclerosis.
Furukawa Y; Tokuda E
Adv Exp Med Biol; 2017; 925():1-12. PubMed ID: 27311318
[TBL] [Abstract][Full Text] [Related]
8. Molecular pathology and genetic advances in amyotrophic lateral sclerosis: an emerging molecular pathway and the significance of glial pathology.
Ince PG; Highley JR; Kirby J; Wharton SB; Takahashi H; Strong MJ; Shaw PJ
Acta Neuropathol; 2011 Dec; 122(6):657-71. PubMed ID: 22105541
[TBL] [Abstract][Full Text] [Related]
9. FUS-immunoreactive inclusions are a common feature in sporadic and non-SOD1 familial amyotrophic lateral sclerosis.
Deng HX; Zhai H; Bigio EH; Yan J; Fecto F; Ajroud K; Mishra M; Ajroud-Driss S; Heller S; Sufit R; Siddique N; Mugnaini E; Siddique T
Ann Neurol; 2010 Jun; 67(6):739-48. PubMed ID: 20517935
[TBL] [Abstract][Full Text] [Related]
10. Elimination of TDP-43 inclusions linked to amyotrophic lateral sclerosis by a misfolding-specific intrabody with dual proteolytic signals.
Tamaki Y; Shodai A; Morimura T; Hikiami R; Minamiyama S; Ayaki T; Tooyama I; Furukawa Y; Takahashi R; Urushitani M
Sci Rep; 2018 Apr; 8(1):6030. PubMed ID: 29662239
[TBL] [Abstract][Full Text] [Related]
11. FUS mutations in amyotrophic lateral sclerosis: clinical, pathological, neurophysiological and genetic analysis.
Blair IP; Williams KL; Warraich ST; Durnall JC; Thoeng AD; Manavis J; Blumbergs PC; Vucic S; Kiernan MC; Nicholson GA
J Neurol Neurosurg Psychiatry; 2010 Jun; 81(6):639-45. PubMed ID: 19965854
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic reduction of ataxin-2 extends lifespan and reduces pathology in TDP-43 mice.
Becker LA; Huang B; Bieri G; Ma R; Knowles DA; Jafar-Nejad P; Messing J; Kim HJ; Soriano A; Auburger G; Pulst SM; Taylor JP; Rigo F; Gitler AD
Nature; 2017 Apr; 544(7650):367-371. PubMed ID: 28405022
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylated TDP-43 (pTDP-43) aggregates in the axial skeletal muscle of patients with sporadic and familial amyotrophic lateral sclerosis.
Cykowski MD; Powell SZ; Appel JW; Arumanayagam AS; Rivera AL; Appel SH
Acta Neuropathol Commun; 2018 Apr; 6(1):28. PubMed ID: 29653597
[TBL] [Abstract][Full Text] [Related]
14. Conjoint pathologic cascades mediated by ALS/FTLD-U linked RNA-binding proteins TDP-43 and FUS.
Ito D; Suzuki N
Neurology; 2011 Oct; 77(17):1636-43. PubMed ID: 21956718
[TBL] [Abstract][Full Text] [Related]
15. Cdc48/VCP and Endocytosis Regulate TDP-43 and FUS Toxicity and Turnover.
Liu G; Byrd A; Warner AN; Pei F; Basha E; Buchanan A; Buchan JR
Mol Cell Biol; 2020 Jan; 40(4):. PubMed ID: 31767634
[TBL] [Abstract][Full Text] [Related]
16. Juvenile ALS with basophilic inclusions is a FUS proteinopathy with FUS mutations.
Bäumer D; Hilton D; Paine SM; Turner MR; Lowe J; Talbot K; Ansorge O
Neurology; 2010 Aug; 75(7):611-8. PubMed ID: 20668261
[TBL] [Abstract][Full Text] [Related]
17. Connecting RNA-Modifying Similarities of TDP-43, FUS, and SOD1 with MicroRNA Dysregulation Amidst A Renewed Network Perspective of Amyotrophic Lateral Sclerosis Proteinopathy.
Pham J; Keon M; Brennan S; Saksena N
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32422969
[TBL] [Abstract][Full Text] [Related]
18. Aggresome formation and liquid-liquid phase separation independently induce cytoplasmic aggregation of TAR DNA-binding protein 43.
Watanabe S; Inami H; Oiwa K; Murata Y; Sakai S; Komine O; Sobue A; Iguchi Y; Katsuno M; Yamanaka K
Cell Death Dis; 2020 Oct; 11(10):909. PubMed ID: 33097688
[TBL] [Abstract][Full Text] [Related]
19. [Molecular mechanism of amyotrophic lateral sclerosis (ALS) from the viewpoint of the formation and degeneration of transactive response DNA-binding protein 43 kDa (TDP-43) inclusions].
Kasahara S; Ishihara T; Koike Y; Sugai A; Onodera O
Rinsho Shinkeigaku; 2020 Feb; 60(2):109-116. PubMed ID: 31956195
[TBL] [Abstract][Full Text] [Related]
20. [The FUS protein: Physiological functions and a role in amyotrophic lateral sclerosis].
Efimova AD; Ovchinnikov RK; Roman AY; Maltsev AV; Grigoriev VV; Kovrazhkina EA; Skvortsova VI
Mol Biol (Mosk); 2017; 51(3):387-399. PubMed ID: 28707655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
